Phase II, Double blind, Randomized, Placebo controlled, Parallel group,
Trial to Explore the Potential Anti-dyskinetic Properties of CPL500036 (PDE10A inhibitor)
in Patients with Parkinson's Disease Suffering from Levodopa Induced Dyskinesia
Log in
BioStat is responsible for data management and statistical analysis.